Profile data is unavailable for this security.
About the company
Rakovina Therapeutics Inc. is a Canada-based biopharmaceutical company. The Company is engaged in advancing cancer therapies based on deoxyribonucleic acid (DNA)-damage response technologies. The Company has a pipeline of DNA-damage response inhibitors to advance one or more drug candidates into human clinical trials and obtain marketing approval for cancer therapeutics. The Company’s research programs include kt-2000, kt-3000 and kt-4000. The kt-2000 next generation PARP-inhibitors. The kt-3000 class drug candidates are rationally designed to overcome treatment resistance by selectively downregulating DNA double-strand (DSB) repair mechanisms while enhancing PARP inhibitor activity. The kt-4000 series lead candidates release a potent methylation agent causing damage to a tumor cell’s DNA while also inhibiting DNA-damage repair mechanisms to cancer cell death.
- Revenue in CAD (TTM)0.00
- Net income in CAD-2.94m
- Incorporated2019
- Employees--
- LocationRakovina Therapeutics Inc105 - 1008 Beach AvenueVancouver V6E 1T7CanadaCAN
- Phone+1 (604) 619-0225
- Fax+1 (604) 980-6264
- Websitehttps://www.rakovinatherapeutics.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
StageZero Life Sciences Ltd | -100.00bn | -100.00bn | 4.94m | 40.00 | -- | -- | -- | -- | -- | -- | -- | -0.1192 | -- | -- | -- | -- | -- | -135.76 | -- | -- | -- | -2.74 | -- | -246.92 | 0.0204 | -- | -- | -- | -25.12 | 55.93 | -52.53 | -- | -- | -- |
Quest PharmaTech Inc | 0.00 | 13.58m | 5.10m | 0.00 | 0.3737 | 0.2205 | 0.3754 | -- | 0.0803 | 0.0803 | 0.00 | 0.136 | 0.00 | -- | -- | -- | 53.30 | 7.62 | 55.60 | 8.45 | -- | -- | -- | -- | -- | -- | 0.0417 | 0.00 | -- | -- | 95.35 | -- | -- | -- |
Hemostemix Inc | 0.00 | -1.94m | 5.25m | -- | -- | -- | -- | -- | -0.0214 | -0.0214 | 0.00 | -0.0959 | 0.00 | -- | -- | -- | -705.31 | -599.98 | -- | -- | -- | -- | -- | -- | -- | -1.74 | -- | -- | -- | -- | 52.21 | -- | -- | -- |
Innovotech Inc | 1.23m | -364.50k | 5.30m | 16.00 | -- | 7.22 | -- | 4.31 | -0.0094 | -0.0094 | 0.0315 | 0.0187 | 1.10 | 5.81 | 5.84 | -- | -32.59 | 2.90 | -37.99 | 3.56 | 68.63 | 71.56 | -29.67 | 2.19 | 2.17 | -- | 0.1115 | -- | 5.05 | 7.42 | -15.43 | -- | 35.69 | -- |
Principal Technologies Inc | 618.64k | -1.90m | 5.93m | -- | -- | 9.72 | -- | 9.58 | -0.0766 | -0.0766 | 0.0246 | 0.0165 | 0.5664 | -- | 2.92 | -- | -170.72 | -- | -445.11 | -- | 21.57 | -- | -301.45 | -- | -- | -31.95 | 0.0959 | -- | 25.43 | -- | 23.53 | -- | -- | -- |
Marvel Biosciences Corp | 0.00 | -2.10m | 6.75m | -- | -- | -- | -- | -- | -0.0529 | -0.0529 | 0.00 | -0.0693 | 0.00 | -- | -- | -- | -268.48 | -- | -- | -- | -- | -- | -- | -- | -- | -14.33 | -- | -- | -- | -- | 10.29 | -- | -- | -- |
XORTX Therapeutics Inc | 0.00 | -2.03m | 6.80m | 3.00 | -- | 1.82 | -- | -- | -0.6868 | -0.6868 | 0.00 | 1.28 | 0.00 | -- | -- | -- | -23.54 | -35.42 | -29.36 | -40.37 | -- | -- | -- | -- | -- | -- | 0.03 | -- | -- | -- | 72.04 | -- | 7.91 | -- |
Rakovina Therapeutics Inc | 0.00 | -2.94m | 8.16m | -- | -- | 1.99 | -- | -- | -0.0419 | -0.0419 | 0.00 | 0.0452 | 0.00 | -- | -- | -- | -46.65 | -- | -51.51 | -- | -- | -- | -- | -- | -- | -13.01 | 0.2652 | -- | -- | -- | 6.39 | -- | -- | -- |
Medicure Inc | 20.93m | -2.63m | 9.60m | 25.00 | -- | 0.4914 | -- | 0.4587 | -0.2529 | -0.2529 | 1.94 | 1.87 | 0.7288 | 2.28 | 4.38 | 837,280.00 | -9.16 | -13.42 | -12.73 | -18.28 | 61.41 | 61.87 | -12.56 | -27.38 | 1.42 | -- | 0.0202 | -- | -5.94 | -5.71 | -167.55 | -- | -28.82 | -- |
Numinus Wellness Inc | 20.10m | -24.36m | 9.71m | -- | -- | 2.08 | -- | 0.4832 | -0.0906 | -0.0946 | 0.0752 | 0.0145 | 0.8572 | -- | 11.72 | -- | -103.89 | -77.31 | -129.39 | -84.20 | 30.80 | -- | -121.19 | -323.32 | -- | -13.08 | 0.6044 | -- | 256.95 | -- | 32.59 | -- | -- | -- |
Telo Genomics Corp | 0.00 | -2.97m | 11.98m | 8.00 | -- | 19.03 | -- | -- | -0.0434 | -0.0434 | 0.00 | 0.0084 | 0.00 | -- | -- | 0.00 | -323.36 | -85.03 | -407.98 | -113.86 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -33.66 | -- | 24.41 | -- |